2026-526983-19-00Not yet recruitingPhase 1
A clinical trial of MK-1568 in participants with prostate cancer (MK-1568-001)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 3 Nov 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 10 Sept 2026
- Start date
- 24 Dec 2026
- Lead sponsor
- Merck Sharp & Dohme LLC
- Diseases
- Prostate cancer
- EU CT number
- 2026-526983-19-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 15
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting | Amsterdam | Netherlands | Not yet recruiting |
| Radboud universitair medisch centrum Stichting | Nijmegen | Netherlands | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.